OROrion Oyj ORINY · OTC
$53.25 +4.56% (+$2.32)
- Market cap
- 24.8B €
- Enterprise value
- 24.8B €
- P/E
- 42.2x
- Forward P/E
- 19.2x
- PEG
- 1.1x
- P/S
- 12.1x
- P/FCF
- 64.4x
- EV/EBITDA
- 31.6x
- ROIC
- 40.6%
- Bruto marža
- 65.9%
- Neto marža
- 28.5%
- Dividend yield
- 2.07%
- Payout ratio
- 87.2%
- Neto dolg/EBITDA
- 0.0x
- Beta
- 0.29
- Free float
- 44.0%
O podjetju
Orion Oyj is a Finnish pharmaceutical company headquartered in Espoo, focused on the research, development, manufacturing, and distribution of medicines and healthcare products. The company specializes in treatments for neurological and respiratory diseases, oncology, and urological disorders, while also offering a wide range of generic medicines and veterinary products. Orion operates not only in Finland but also internationally, in collaboration with various global partners. The company is recognized for its long-standing scientific heritage, high-quality standards, and strong focus on innovations that enhance patients’ quality of life.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Aino Anna Liisa Hurme
Employees
4,029
Headquarters
Espoo
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke